BFLY vs GIPL vs IDXX Stock Comparison

Butterfly Network, Global Innovative Platforms and Idexx Laboratories Prices as of Nov 3, 2026 Peers: Industry group
1 more company in this comparison (NEOG) Create a free account to keep reading and compare up to 10 companies.
BFLY Butterfly Network, Inc.
$6.40 -28.3% 1M +119.9% 1Y
Market cap
$1.78B
P/E
–
Revenue (TTM)
$123.25M
Div. yield
–
Diagnostic Equipment Healthcare
2 wins

Head to Head

8 decided of 12

Idexx Laboratories leads on 5 of the 12 questions below (Idexx Laboratories 5, Butterfly Network 2, Global Innovative Platforms 1). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionBFLYGIPLIDXXLeader
Larger companyMarket capitalisation $1.78B $2.49M $55.06B IDXX
Cheaper on earningsLower P/E, profitable companies only -33.2x -3.6x 46.6x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS — — 43.0x –
Faster revenue growthRevenue growth, trailing twelve months +39.4% — +11.9% BFLY
More profitableNet margin, trailing twelve months -43.6% -361.7% 25.4% IDXX
Better return on capitalReturn on invested capital — — 45.4% –
Less leveragedLower net debt / EBITDA — 0.4x 0.4x GIPL
Higher dividend yieldTrailing dividend yield 0.00% — 0.00% –
Better 1-year returnPrice return, last 12 months +119.9% -93.8% -7.0% BFLY
Better 5-year returnAnnualised price return, 5 years -9.4%/yr -60.2%/yr +1.0%/yr IDXX
Less volatileAnnualised volatility, 1 year 112.7% 356.7% 35.4% IDXX
Higher overall scoreMean of the five percentile scores vs peers 50/100 42/100 77/100 IDXX

Percentile Scorecard

BFLYGIPLIDXX

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisBFLYGIPLIDXX
Valuation 29 #164 of 229 28 #459 of 634 75 #157 of 634
Growth 90 #24 of 221 26 #449 of 607 72 #169 of 607
Profitability 38 #130 of 209 40 #336 of 557 97 #17 of 557
Financial Health 57 #103 of 240 98 #12 of 654 48 #342 of 654
Shareholder Returns 36 #95 of 147 17 #333 of 401 94 #27 of 401
Overall 50 42 77
  • BFLY ranked among 248 companies in Medical Devices and Diagnostics
  • GIPL ranked among 671 companies in Pharmaceuticals and Biotechnology
  • IDXX ranked among 671 companies in Pharmaceuticals and Biotechnology

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodBFLYGIPLIDXXSPY
1 month -28.3%-90.0%+29.6% -2.0%
3 months -27.4%-88.9%+14.3% -2.2%
6 months +32.8%-90.4%+19.4% +4.2%
Year to date +68.4%-54.5%-0.7% +10.6%
1 year +119.9%-93.8%-7.0% +10.4%
3 years +471.4%-95.2%+56.5% +73.6%
3 years, per year +78.9%-63.8%+16.1% +20.2%
5 years -38.8%-99.0%+5.0% +61.6%
5 years, per year -9.4%-60.2%+1.0% +10.1%
10 years —-98.3%+539.6% +261.3%
10 years, per year —-33.6%+20.4% +13.7%

Risk

MeasureBFLYGIPLIDXXSPY
Volatility, 1Y 112.7%356.7%35.4% 12.8%
Downside volatility, 1Y 94.2%2,018.7%31.8% 12.8%
Beta vs S&P 500, 1Y 3.094.860.75 1.00
Return / volatility, 1Y 1.06-0.26-0.20 0.81
Max drawdown, 5Y -93.3%-99.0%-50.9% -25.4%
From 52-week high -35.6%-94.9%-12.3% -3.2%
52-week high $9.94$0.99$766.68 $779.14
52-week low $1.97$0.05$504.70 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleBFLYGIPLIDXX
P/E now vs peer median -31.2xmedian 28.1x -3.6xmedian 18.4x 44.8xmedian 18.4x
P/S now vs peer median 12.8xmedian 2.9x 13.3xmedian 9.0x 11.4xmedian 9.0x
EV/EBITDA now vs peer median -28.5xmedian 18.0x -3.6xmedian 16.0x 32.2xmedian 16.0x
P/FCF now vs peer median -57.1xmedian 24.8x -3.2xmedian 21.8x 40.6xmedian 21.8x
P/B now vs peer median 8.5xmedian 2.3x 4.7xmedian 2.1x 28.3xmedian 2.1x
PEG now vs peer median -1.04median 0.95 -0.06median 0.37 2.96median 0.37

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsBFLYGIPLIDXX
Revenue $123.25M $187.20K $4.66B
Gross profit $86.60M – $2.92B
Operating income -$57.83M -$677.04K $1.51B
Net income -$53.69M -$677.04K $1.18B
Free cash flow -$27.55M -$766.04K $1.30B
R&D $39.57M $377.99K $266.87M
EPS (diluted) $-0.20 $-0.02 $14.96
Cash & equivalents $122.30M $244.24K $197.54M
Total debt – $5.62K $848.88M
Shares (diluted) 262.10M 44.54M 79.05M
Enterprise value $1.25B $1.88M $54.28B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricBFLYGIPLIDXX
P/E -31.2x -3.6x 44.8x
P/FCF -57.1x -3.2x 40.6x
P/Operating cash flow -67.3x -3.5x 37.3x
P/S 12.8x 13.3x 11.4x
P/B 8.5x 4.7x 28.3x
P/Tangible book 8.8x 4.7x 30.2x
EV/EBITDA -28.5x -3.6x 32.2x
EV/EBIT -25.1x -3.3x 35.6x
EV/Revenue 11.8x 12.0x 11.5x
EV/FCF -52.7x -2.9x 41.1x
EV/Operating cash flow -62.0x -3.2x 37.8x
PEG (3Y EPS CAGR) -1.04 -0.06 2.96

Growth

14 metrics
MetricBFLYGIPLIDXX
Revenue growth (1Y) 39.4% – 11.9%
Revenue CAGR (3Y) 21.7% – 9.1%
Gross profit growth (1Y) 126.4% – 13.7%
Gross profit CAGR (3Y) 30.5% – 10.8%
Operating income growth (1Y) 33.5% -20.9% 15.3%
Operating income CAGR (3Y) 26.9% -51.6% 11.8%
Net income growth (1Y) 32.8% -20.9% 15.1%
Net income CAGR (3Y) 24.2% -51.6% 12.8%
EPS growth (1Y) 35.4% -9.8% 17.4%
EPS CAGR (3Y) 30.0% 63.5% 15.1%
Operating cash flow growth (1Y) 5.8% 15.8% 30.4%
Operating cash flow CAGR (3Y) 41.1% -96.8% 19.6%
Free cash flow growth (1Y) -0.1% 9.2% 35.3%
Free cash flow CAGR (3Y) 38.8% -101.8% 24.2%

Profitability

14 metrics
MetricBFLYGIPLIDXX
Gross margin 70.3% – 62.7%
EBITDA margin -41.4% -333.4% 35.7%
Operating margin -46.9% -361.7% 32.3%
Pretax margin -43.5% -361.7% 31.7%
Net margin -43.6% -361.7% 25.4%
FCF margin -22.4% -409.2% 28.0%
Operating cash flow margin -19.0% -379.8% 30.4%
Return on equity -28.7% -120.8% 67.9%
Return on assets -18.8% -119.7% 33.1%
Return on invested capital – – 45.4%
Return on capital employed -26.6% -121.4% 65.2%
Asset turnover 0.4x 0.3x 1.3x
Cash conversion (OCF / net income) 0.4x 1.1x 1.2x
Stock comp / revenue 20.8% – 1.4%

Financial Health

11 metrics
MetricBFLYGIPLIDXX
Debt / assets – 1.0% 22.9%
Debt / equity – 0.0x 0.5x
Net debt / EBITDA – 0.4x 0.4x
Debt / FCF – 0.0x 0.7x
Liabilities / assets 36.0% 1.4% 49.6%
Equity / assets 64.0% 98.6% 50.4%
Interest coverage -46.8x – 43.5x
Current ratio 3.6x 34.7x 1.2x
Quick ratio 2.3x 33.2x 0.7x
Cash ratio 1.8x 31.3x 0.2x
Altman Z-score 5.16 183.95 22.73

Shareholder Returns

7 metrics
MetricBFLYGIPLIDXX
Dividend yield – – –
Net buyback yield -0.5% -32.1% 1.8%
Shareholder yield -0.5% -32.1% 1.8%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusBFLYGIPLIDXX
Forward P/E – – 43.0xFY2026
EPS, next fiscal year $-0.10FY2026 – $15.63FY2026
EPS growth, next FY – – +19.5%FY2026
EPS growth, the year after – – +12.9%
Revenue, next fiscal year $114.50MFY2026 – $5.00BFY2026
Revenue growth, next FY +17.3%FY2026 – +16.3%FY2026
Revenue growth, the year after +26.0% – +0.6%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersBFLYGIPLIDXX
Held by institutions 59.9% – 93.6%
Institutions holding 248 – 1,291
Change in shares held, QoQ +13.9% – +4.1%
Institutions buying 144 – 589
Institutions selling 59 – 496
Buyers to sellers 2.44 – 1.19

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

BFLYGIPLIDXX
BFLY 1.00 0.10 0.22
GIPL 0.10 1.00 0.12
IDXX 0.22 0.12 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, BFLY, GIPL and IDXX?

Idexx Laboratories (IDXX) is the largest by market capitalisation: Butterfly Network (BFLY) $1.78B, Global Innovative Platforms (GIPL) $2.49M, Idexx Laboratories (IDXX) $55.06B.

Which company is growing faster?

Butterfly Network (BFLY) grew revenue fastest over the trailing twelve months: Butterfly Network (BFLY) +39.4%, Idexx Laboratories (IDXX) +11.9%.

Which company is more profitable?

Idexx Laboratories (IDXX) has the highest net margin (Butterfly Network (BFLY) -43.6%, Global Innovative Platforms (GIPL) -361.7%, Idexx Laboratories (IDXX) 25.4%).

Which stock has performed better?

Over the past year Butterfly Network (BFLY) returned the most: Butterfly Network (BFLY) +119.9%, Global Innovative Platforms (GIPL) -93.8%, Idexx Laboratories (IDXX) -7.0%. Over five years, Idexx Laboratories (IDXX) compounded fastest (Butterfly Network (BFLY) -9.4%/yr, Global Innovative Platforms (GIPL) -60.2%/yr, Idexx Laboratories (IDXX) +1.0%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Idexx Laboratories (IDXX) has been the steadiest (Butterfly Network (BFLY) 112.7%, Global Innovative Platforms (GIPL) 356.7%, Idexx Laboratories (IDXX) 35.4%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, BFLY, GIPL and IDXX?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Idexx Laboratories (IDXX) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.